.png){kind=icon}
.png){kind=icon}
Return
Correction: 5-HT4 receptor agonists treatment reduces tau pathology and behavioral deficit in the PS19 mouse model of tauopathy
.png){kind=icon}
OA
AI
S
E
A
R
M
H
M
N
DOI：10.3389/fncel.2026.1945844.png)
.png){kind=icon}
Original request for help.png){kind=icon}
Share.png){kind=icon}
Save
Abstract
En
Keywords:
Alzheimer's disease
tauopathy
ubiquitin proteasome system (UPS)
5-HT4 agonist
synaptic therapy
Journal
IF:
4
Papers:
6.4K
Citations:
2.3W
Organization
Cited Papers